Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Advances in therapy"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Peng%2C+Ye%22&type=Person&filter%5B%5D=journalStr%3A%22Advances+in+therapy%22
/vufind/Search/Results?lookfor=%22Peng%2C+Ye%22&type=Person&filter%5B%5D=journalStr%3A%22Advances+in+therapy%22
Search /vufind/Search2/Results?lookfor=%22Peng%2C+Ye%22&type=Person&filter%5B%5D=journalStr%3A%22Advances+in+therapy%22
PubPharm (32)
1
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA
enthalten in:
Advances in therapy
| 2022
von
Wang, J.
|
Yi, Y.
|
Wan, X.
| +3
Wird geladen...
2
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA
enthalten in:
Advances in therapy
| 2022
von
Wang, J.
|
Yi, Y.
|
Wan, X.
| +3
Wird geladen...
3
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA
enthalten in:
Advances in therapy
| 2022
von
Wang, J.
|
Yi, Y.
|
Wan, X.
| +3
Wird geladen...
4
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA
enthalten in:
Advances in therapy
| 2022
von
Wang, J.
|
Yi, Y.
|
Wan, X.
| +3
Wird geladen...
5
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
She, Z.
|
Peng, L.
| +8
Wird geladen...
6
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
She, Z.
|
Peng, L.
| +8
Wird geladen...
7
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
She, Z.
|
Peng, L.
| +8
Wird geladen...
8
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States
enthalten in:
Advances in therapy
| 2021
von
Peng, Y.
|
She, Z.
|
Peng, L.
| +8
Wird geladen...
9
Cost-Effectiveness Analysis of Cemiplimab Versus Chemotherapy as First-Line Treatment in Advanced NSCLC with PD-L1 Expression Levels of at Least 50
enthalten in:
Advances in therapy
| 2021
von
Wang, L.
|
Peng, Y.
|
Zeng, X.
| +5
Wird geladen...
10
Cost-Effectiveness Analysis of Cemiplimab Versus Chemotherapy as First-Line Treatment in Advanced NSCLC with PD-L1 Expression Levels of at Least 50%
enthalten in:
Advances in therapy
| 2021
von
Wang, L.
|
Peng, Y.
|
Zeng, X.
| +5
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Advances in therapy
Medienart
32
Aufsätze
24
E-Artikel
24
E-Ressourcen
8
Gedruckte Aufsätze
Zeitschriftentitel
Advances in therapy
Thema
32
Cost-effectiveness
28
Markov model
8
Atezolizumab
8
Journal Article
8
Non-small cell lung cancer
8
Research Support, Non-U.S. Gov't
8
Urothelial carcinoma
4
Anaplastic lymphoma kinase
4
Antibodies, Monoclonal, Humanized
4
Avelumab
4
Bladder cancer
4
Breast cancer
4
Cemiplimab
4
Ceritinib
4
China
4
Daratumumab
4
Lung cancer
4
Multiple myeloma
4
NSCLC
4
Nivolumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
28
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
32
Englisch
Haven't found what you're looking for?
Wird geladen...